Correlation between the use of statins and COVID-19: what do we know?

Vitiello, Antonio; La Porta, Raffaele; Ferrara, Francesco

Vitiello, Antonio; La Porta, Raffaele; Ferrara, Francesco.

Vitiello A; Pharmaceutical Department, USL 1 Umbria, Perugia, Italy antonio.vitiello2@uslumbria1.it.
La Porta R; Clinical Pathology Department, AV1 Asur Marche, Urbino, Italy.
Ferrara F; Pharmaceutical Department, USL 1 Umbria, Perugia, Italy.

BMJ Evid Based Med ; 27(2): 126-127, 2022 04.

Article in English | MEDLINE | ID: covidwho-955473

Subject(s)

COVID-19; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use

Keywords

cardiovascular diseases

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / COVID-19 Limits: Humans Language: English Journal: BMJ Evid Based Med Year: 2022 Document Type: Article Affiliation country: Bmjebm-2020-111589

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google